Team:Hong Kong-CUHK

From 2012.igem.org

(Difference between revisions)
Line 64: Line 64:
           <table width="900" border="0" cellspacing="0" cellpadding="0" style="width:900px">
           <table width="900" border="0" cellspacing="0" cellpadding="0" style="width:900px">
             <tr>
             <tr>
-
               <td><table border="0" cellpadding="0" cellspacing="0" width="900" style="width:900px" >
+
               <td><table border="0" cellpadding="0" cellspacing="0" width="900" style="width:900px">
                 <!-- fwtable fwsrc="menu 900.png" fwpage="Page 1" fwbase="menu 900.jpg" fwstyle="Dreamweaver" fwdocid = "2088843928" fwnested="0" -->
                 <!-- fwtable fwsrc="menu 900.png" fwpage="Page 1" fwbase="menu 900.jpg" fwstyle="Dreamweaver" fwdocid = "2088843928" fwnested="0" -->
                 <tr>
                 <tr>
Line 99: Line 99:
                 </tr>
                 </tr>
                 <tr>
                 <tr>
-
                   <td style="background-color:#FFFFFF" valign="top" bgcolor="#ffffff"><p style="margin:0px"></p></td>
+
                   <td valign="top" bgcolor="#ffffff" style="background-color:#FFFFFF"><p style="margin:0px"></p></td>
-
                   <td style="background-color:#FFFFFF" valign="top" bgcolor="#ffffff"><p style="margin:0px"></p></td>
+
                   <td valign="top" bgcolor="#ffffff" style="background-color:#FFFFFF"><p style="margin:0px"></p></td>
-
                   <td style="background-color:#FFFFFF" valign="top" bgcolor="#ffffff"><p style="margin:0px"></p></td>
+
                   <td valign="top" bgcolor="#ffffff" style="background-color:#FFFFFF"><p style="margin:0px"></p></td>
                   <td><img src="https://static.igem.org/mediawiki/2012/5/52/Spacer.gif" alt="" name="undefined_2" width="1" height="1" id="undefined_2" /></td>
                   <td><img src="https://static.igem.org/mediawiki/2012/5/52/Spacer.gif" alt="" name="undefined_2" width="1" height="1" id="undefined_2" /></td>
             </tr>
             </tr>
Line 113: Line 113:
         <td valign="top"><p>&nbsp;</p>
         <td valign="top"><p>&nbsp;</p>
           <!-- InstanceBeginEditable name="content" -->
           <!-- InstanceBeginEditable name="content" -->
-
<p>&nbsp;</p>
+
          <p>&nbsp;</p>
           <p class="aloveofthunder">WELCOME!</p>
           <p class="aloveofthunder">WELCOME!</p>
-
           <p>Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr,  sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr,  sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.</p>
+
           <p>When Alexander Fleming won the Nobel Prize in Physiology or Medicine in 1945 for his discovery of the first antibiotic penicillin, he acknowledged and warned the world that the misusage of antibiotics would bring a threat of antibiotic resistant microbes. Indeed, in the past decades, the occurrence of antibiotics resistance in microbes has appeared more frequently and it has become more difficult to treat these infections. Therefore, we aim to manipulate a bacterial immune system, CRISPR/Cas to combat antibiotic resistance.</p>
 +
 
 +
<p>The CRISPR/Cas system is the adaptive immune system presented in many bacteria, and it protects them from the invading genetic materials such as the viral DNA. When a foreign double stranded DNA (dsDNA) invade these specific bacteria, a portion of the DNA is captured by their system and incorporated into spacer sequence. Further invasion of the same dsDNA is recognized by the spacers incorporated earlier and destroyed by the CRISPR-associated protein, Cas3. Through engineering the spacer sequence, we can make the system target any dsDNA that is complementary to the spacer(s). </p>
 +
 
 +
<p>How are we going to make use of such intrinsic system to fight against the antibiotic resistant microbes? Bacillus subtilis could have their materials exchanged with both gram positive and negative bacteria through forming nanotubes. As B. subtilis lack of the CRISPR/Cas system, we need to engineer this immune system into B. subtilis. Upon the success of such implantation, the immune components could pass to the others’ cytoplasm through the nanotubes in between, and by manipulating the spacer sequence, the antibiotic resistance gene and any other DNA sequence of interest can be destroyed.
 +
</p>
           <!--          <table width="900" border="0" cellspacing="0" cellpadding="5">-->
           <!--          <table width="900" border="0" cellspacing="0" cellpadding="5">-->
           <table width="900" border="0" cellspacing="0" cellpadding="0">
           <table width="900" border="0" cellspacing="0" cellpadding="0">
Line 130: Line 135:
       </tr>
       </tr>
       <tr>
       <tr>
-
<!--        <td align="center"><hr width="100%" class="horizontalrule" />-->
 
         <td align="center" style="background-color:#FFFFFF; text-align:center"><hr width="100%" class="horizontalrule" />
         <td align="center" style="background-color:#FFFFFF; text-align:center"><hr width="100%" class="horizontalrule" />
           <p><a href="file:///VIVIAN LI 2/iGEM/home.html">Home</a> &nbsp;&nbsp;|  &nbsp;&nbsp;<a href="file:///VIVIAN LI 2/iGEM/team.html">Team</a>&nbsp;&nbsp; | &nbsp;&nbsp;<a href="file:///VIVIAN LI 2/iGEM/project.html">Project</a> &nbsp;&nbsp;| &nbsp;&nbsp;<a href="file:///VIVIAN LI 2/iGEM/lab.html">Laboratory</a>&nbsp;&nbsp; | &nbsp;&nbsp;<a href="file:///VIVIAN LI 2/iGEM/human.html">Human Practice</a>&nbsp;&nbsp; |&nbsp;&nbsp; <a href="file:///VIVIAN LI 2/iGEM/sponsors.html">Sponsors&nbsp;</a>&nbsp; | &nbsp;&nbsp;<a href="contact.html">Contact Us!</a></p></td>
           <p><a href="file:///VIVIAN LI 2/iGEM/home.html">Home</a> &nbsp;&nbsp;|  &nbsp;&nbsp;<a href="file:///VIVIAN LI 2/iGEM/team.html">Team</a>&nbsp;&nbsp; | &nbsp;&nbsp;<a href="file:///VIVIAN LI 2/iGEM/project.html">Project</a> &nbsp;&nbsp;| &nbsp;&nbsp;<a href="file:///VIVIAN LI 2/iGEM/lab.html">Laboratory</a>&nbsp;&nbsp; | &nbsp;&nbsp;<a href="file:///VIVIAN LI 2/iGEM/human.html">Human Practice</a>&nbsp;&nbsp; |&nbsp;&nbsp; <a href="file:///VIVIAN LI 2/iGEM/sponsors.html">Sponsors&nbsp;</a>&nbsp; | &nbsp;&nbsp;<a href="contact.html">Contact Us!</a></p></td>

Revision as of 08:50, 26 August 2012



 

 

Check out our FACEBOOK page!

iGEM - CUHK - 2012

 

 

WELCOME!

When Alexander Fleming won the Nobel Prize in Physiology or Medicine in 1945 for his discovery of the first antibiotic penicillin, he acknowledged and warned the world that the misusage of antibiotics would bring a threat of antibiotic resistant microbes. Indeed, in the past decades, the occurrence of antibiotics resistance in microbes has appeared more frequently and it has become more difficult to treat these infections. Therefore, we aim to manipulate a bacterial immune system, CRISPR/Cas to combat antibiotic resistance.

The CRISPR/Cas system is the adaptive immune system presented in many bacteria, and it protects them from the invading genetic materials such as the viral DNA. When a foreign double stranded DNA (dsDNA) invade these specific bacteria, a portion of the DNA is captured by their system and incorporated into spacer sequence. Further invasion of the same dsDNA is recognized by the spacers incorporated earlier and destroyed by the CRISPR-associated protein, Cas3. Through engineering the spacer sequence, we can make the system target any dsDNA that is complementary to the spacer(s).

How are we going to make use of such intrinsic system to fight against the antibiotic resistant microbes? Bacillus subtilis could have their materials exchanged with both gram positive and negative bacteria through forming nanotubes. As B. subtilis lack of the CRISPR/Cas system, we need to engineer this immune system into B. subtilis. Upon the success of such implantation, the immune components could pass to the others’ cytoplasm through the nanotubes in between, and by manipulating the spacer sequence, the antibiotic resistance gene and any other DNA sequence of interest can be destroyed.

 

ABOUT iGEM

Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero eros et accumsan et iusto odio dignissim qui blandit praesent luptatum zzril delenit augue duis dolore te feugait nulla facilisi. Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero eros et accumsan et iusto odio dignissim qui blandit praesent luptatum zzril delenit augue duis dolore te feugait nulla facilisi.

 


Home   |   Team   |   Project   |   Laboratory   |   Human Practice   |   Sponsors   |   Contact Us!

©Copyright CUHK IGEM Team 2012